Monoaminergic Markers Across the Cognitive Spectrum of Lewy Body Disease
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Monoaminergic Markers Across the Cognitive Spectrum of Lewy Body Disease
Authors
Keywords
-
Journal
Journal of Parkinsons Disease
Volume 8, Issue 1, Pages 71-84
Publisher
IOS Press
Online
2018-02-21
DOI
10.3233/jpd-171228
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Aging rather than aneuploidy affects monoamine neurotransmitters in brain regions of Down syndrome mouse models
- (2017) Alain D. Dekker et al. NEUROBIOLOGY OF DISEASE
- Targeting the norepinephrinergic system in Parkinson's disease and related disorders: The locus coeruleus story
- (2017) Yannick Vermeiren et al. NEUROCHEMISTRY INTERNATIONAL
- Diagnosis and management of dementia with Lewy bodies
- (2017) Ian G. McKeith et al. NEUROLOGY
- Cerebrospinal fluid biomarkers for Parkinson's disease - a systematic review
- (2016) A. D. Andersen et al. ACTA NEUROLOGICA SCANDINAVICA
- Cognitive function in the early phase of Parkinson's disease, a five-year follow-up
- (2015) M. E. Domellöf et al. ACTA NEUROLOGICA SCANDINAVICA
- Serotonin in Parkinson's disease
- (2015) Marios Politis et al. BEHAVIOURAL BRAIN RESEARCH
- Stabilization of Alpha-Synuclein Oligomers In Vitro by the Neurotransmitters, Dopamine and Norepinephrine: The Effect of Oxidized Catecholamines
- (2015) Andrew F. Fischer et al. NEUROCHEMICAL RESEARCH
- The monoaminergic footprint of depression and psychosis in dementia with Lewy bodies compared to Alzheimer’s disease
- (2015) Yannick Vermeiren et al. Alzheimers Research & Therapy
- Diagnostic value of MIBG cardiac scintigraphy for differential dementia diagnosis
- (2014) Sylvie Slaets et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- Novel and sensitive reversed-phase high-pressure liquid chromatography method with electrochemical detection for the simultaneous and fast determination of eight biogenic amines and metabolites in human brain tissue
- (2014) Debby Van Dam et al. JOURNAL OF CHROMATOGRAPHY A
- CSF biomarkers and clinical progression of Parkinson disease
- (2014) S. Hall et al. NEUROLOGY
- Serotonin Impairment in CSF of PD Patients, without an Apparent Clinical Counterpart
- (2014) Enrica Olivola et al. PLoS One
- Addition of MHPG to Alzheimer's disease biomarkers improves differentiation of dementia with Lewy bodies from Alzheimer's disease but not other dementias
- (2013) Megan K. Herbert et al. Alzheimers & Dementia
- Behavioral correlates of cerebrospinal fluid amino acid and biogenic amine neurotransmitter alterations in dementia
- (2012) Yannick Vermeiren et al. Alzheimers & Dementia
- Dysfunction of the locus coeruleus-norepinephrine system and related circuitry in Parkinson's disease-related dementia
- (2012) K. Del Tredici et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Progression of monoaminergic dysfunction in Parkinson's disease: A longitudinal 18F-dopa PET study
- (2011) Nicola Pavese et al. NEUROIMAGE
- CSF amyloid 1-42 predicts cognitive decline in Parkinson disease
- (2010) A. Siderowf et al. NEUROLOGY
- Diagnostic performance of a CSF-biomarker panel in autopsy-confirmed dementia
- (2007) Sebastiaan Engelborghs et al. NEUROBIOLOGY OF AGING
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now